Multiple myeloma is the second most prevalent blood cancer worldwide, which, despite tremendous improvement in treatment, remains incurable. The research study will provide clinicians with new and powerful molecular tools for early disease detection, predicting treatment response, and for developing novel treatments for multiple myeloma.